Durable graft-versus-leukaemia effects without donor lymphocyte infusions - results of a phase II study of sequential T-replete allogeneic transplantation for high-risk acute myeloid leukaemia and myelodysplasia-Reference-Cited by-同舟云学术

Durable graft-versus-leukaemia effects without donor lymphocyte infusions - results of a phase II study of sequential T-replete allogeneic transplantation for high-risk acute myeloid leukaemia and myelodysplasia

Published:2017-10-26 Issue:3 Volume:180 Page:346-355
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Davies Jeff K.¹²^ORCID,Hassan Sandra¹,Sarker Shah-Jalal³,Besley Caroline¹,Oakervee Heather²,Smith Matthew²,Taussig David¹²,Gribben John G.¹²^ORCID,Cavenagh Jamie D.¹²

Affiliation:

1. Centre for Haemato-Oncology; Barts Cancer Institute; Queen Mary University of London; London UK

2. Department of Haemato-Oncology; Barts Cancer Centre; St Bartholomew's Hospital; Barts Health NHS Trust; London UK

3. Centre for Experimental Cancer Medicine; Barts Cancer Institute; Queen Mary University of London; London UK

Funder

Cancer Research UK

Medical Research Council

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14980/fullpdf

Reference40 articles.

1. Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence;Besien;Leukaemia & Lymphoma,2009

2. Prognostic index for adult patients with acute myeloid leukemia in first relapse;Breems;Journal of Clinical Oncology,2005

3. Cytoreductive treatment with clofarabine/ara-C combined with reduced-intensity conditioning and allogeneic stem cell transplantation in patients with high-risk, relapsed, or refractory acute myeloid leukemia and advanced myelodysplastic syndrome;Buchholz;European Journal of Haematology,2012

4. A randomized comparison of daunorubicin 90 mg/m2 vs 60 mg/m2 in AML induction: results from the UK NCRI AML17 trial in 1206 patients;Burnett;Blood,2015

5. Transplantation in remission improves the disease-free survival of patients with advanced myelodysplastic syndromes treated with myeloablative T cell-depleted stem cell transplants from HLA-identical siblings;Castro-Malaspina;Biology of Blood and Marrow Transplantation,2008

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic Stem Cell Transplantation in Refractory Acute Myeloid Leukaemia;Cells;2024-04-26

2. Evaluation of six different types of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory acute myelogenous leukemia – a study of the Acute Leukemia Working Party of the EBMT;Leukemia & Lymphoma;2020-10-11

3. The role of allogeneic stem cell transplantation in the management of acute myeloid leukaemia: a triumph of hope and experience;British Journal of Haematology;2019-12-10

4. Very early lineage-specific chimerism after reduced intensity stem cell transplantation is highly predictive of clinical outcome for patients with myeloid disease;Leukemia Research;2019-08

5. From remission to cure: bypass or detour?;British Journal of Haematology;2017-11-28